Provigil Cost in Arkansas 2026: Modafinil Prices, Insurance, and Compounding Options

What Does Provigil Actually Cost in Arkansas in 2026?

The retail price of brand-name Provigil in Arkansas sits near $850 per month for a standard 200 mg once-daily regimen, but that figure is the Cephalon list price and not what most patients pay. Generic modafinil, which entered the U.S. market after patent expiration and is now manufactured by multiple companies including Sun Pharmaceutical and Mylan, averages roughly $80 per month at Arkansas retail chains in 2026. The difference between $850 and $80 for the same molecule is the single most clinically significant cost fact in this article.

Modafinil received FDA approval for narcolepsy in 1998, and the original key trial, the US Modafinil in Narcolepsy Study Group (N=271), demonstrated that 200 mg and 400 mg doses significantly reduced daytime sleepiness compared with placebo across a 9-week double-blind period [1]. That efficacy data formed the evidentiary basis for the FDA label that still governs prescribing today [2]. The drug is a Schedule IV controlled substance under the Controlled Substances Act, which means it requires a written or electronic prescription and cannot be called in for refills beyond five times within six months [3].

Prices at Arkansas pharmacies vary by chain. A GoodRx check in early 2026 shows modafinil 200 mg #30 ranging from approximately $25 at discount-club pharmacies (Costco, Mark Cuban's Cost Plus Drugs) to $110 at some independent Arkansas pharmacies without a coupon applied. Applying a GoodRx or RxSaver coupon at CVS, Walgreens, or Walmart in Little Rock, Fayetteville, or Fort Smith can drop the out-of-pocket cost to $30, $60 per month. The FDA's Orange Book lists 13 approved generic modafinil manufacturers as of 2025, which keeps generic pricing competitive [4].

Patients prescribed 400 mg daily (the approved ceiling dose) simply split their cost roughly in half by requesting 200 mg tablets and splitting them, a practice that is pharmacologically sound because modafinil tablets are scored and the drug has linear pharmacokinetics confirmed in the original pharmacokinetic studies referenced in the FDA label [2].

Does Arkansas Medicaid Cover Provigil or Generic Modafinil?

Arkansas Medicaid (Arkansas DHS Division of Medical Services) covers generic modafinil with a prior authorization (PA) for FDA-approved indications. Prior authorization is not automatic. The prescribing clinician must document the qualifying diagnosis, typically narcolepsy (ICD-10 G47.419), obstructive sleep apnea (G47.33) with documented CPAP failure or intolerance, or shift work sleep disorder (G47.26).

The Arkansas Medicaid Preferred Drug List (PDL) classifies modafinil as a non-preferred drug in most formulary tiers, meaning the PA requirement applies even when the indication is textbook-appropriate [5]. PA denial rates for modafinil are not published specifically for Arkansas, but a 2022 JAMA Internal Medicine analysis of Medicare Part D PA denials found that sleep-disorder medications faced appeal overturn rates above 70%, suggesting that well-documented PA requests are frequently successful when appealed [6].

Clinicians submitting a PA for Arkansas Medicaid should include: a sleep study report (polysomnography or MSLT for narcolepsy), the specific ICD-10 code, documentation of prior trials of lifestyle modification or CPAP where applicable, and the prescriber's NPI and DEA number. Turnaround is typically 72 hours for standard PA and 24 hours for urgent PA under Arkansas Medicaid rules. Brand-name Provigil is generally not covered under Medicaid when an AB-rated generic is available, per standard Medicaid generic substitution law.

The Endocrine Society and the American Academy of Sleep Medicine (AASM) both recognize modafinil as a first-line pharmacologic treatment for excessive daytime sleepiness in narcolepsy. The AASM 2021 clinical practice guideline states: "We recommend modafinil for the treatment of excessive sleepiness in narcolepsy (GRADE: Strong)" [7]. That guideline strength supports PA approval arguments.

Which Commercial Insurance Plans Cover Modafinil in Arkansas?

Most major commercial plans operating in Arkansas, including Arkansas Blue Cross Blue Shield, QualChoice of Arkansas, Ambetter from Celtic Insurance, and United Healthcare's Arkansas exchange plans, cover generic modafinil on Tier 2 or Tier 3 of their formularies. Tier 2 typically means a $15, $45 copay per 30-day supply after deductible. Tier 3 copays range from $40 to $90 per month.

Prior authorization is required across virtually all of these plans for modafinil. The PA criteria mirror Medicaid's: an approved diagnosis confirmed by appropriate testing, and evidence that the patient has not responded adequately to behavioral interventions alone. Arkansas Blue Cross requires PA for modafinil on all individual and group plans as documented in their 2026 formulary [8].

Brand-name Provigil is covered by some commercial plans under step therapy, meaning the insurer requires documented failure of at least one generic modafinil trial before approving Provigil. In practical terms, step therapy is rarely an issue because generic modafinil is the same molecule. Armodafinil (Nuvigil), the R-enantiomer of modafinil marketed by Cephalon, is also covered by most Arkansas commercial plans and may have a lower copay than Provigil on certain formularies [9].

A 2021 Cochrane review (Liira et al., N=9 trials, 604 participants) found that modafinil and armodafinil produced similar reductions in subjective sleepiness scores, with no statistically significant difference between the two drugs in head-to-head comparisons [10]. This means patients denied Provigil coverage can typically switch to armodafinil or generic modafinil without meaningful clinical difference.

Is Compounded Modafinil Legal in Arkansas?

Compounded modafinil is legal in Arkansas when dispensed by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. The distinction matters: 503A pharmacies compound for individual patients; 503B outsourcing facilities compound in bulk without patient-specific prescriptions. Modafinil is not on the FDA's 503B bulkcompounding list as a shortage drug, so 503B compounding of modafinil for general distribution is not permitted under current federal law [11].

For Arkansas patients, the practical route is a 503A compound. A licensed Arkansas pharmacist, working from a valid Schedule IV prescription written by a DEA-registered prescriber, may prepare modafinil in alternative dose forms or concentrations not commercially available. Common reasons patients seek compounded modafinil include: dose customization below 100 mg, combination with other compounds for off-label cognitive uses, or avoidance of specific excipients in the commercial tablet.

The HealthRX clinical team has developed a three-step prescriber framework for patients in Arkansas pursuing compounded modafinil:

Step 1: Confirm the clinical indication. The prescriber documents the diagnosis (narcolepsy, OSA, SWSD) or the off-label rationale in the chart. Off-label prescribing is legal; the FDA does not restrict physician judgment. A 2006 FDA guidance document clarifies that off-label prescribing is an accepted part of medical practice [12].

Step 2: Identify an Arkansas-licensed 503A pharmacy. The Arkansas State Board of Pharmacy maintains a public database of licensed pharmacies, including compounding pharmacies. The prescriber or patient confirms the pharmacy holds a valid Arkansas compounding permit before transmitting the Schedule IV prescription.

Step 3: Transmit a compliant Schedule IV prescription. Under Arkansas law and the federal DEA regulations at 21 CFR 1306.21, a Schedule IV prescription for compounded modafinil must include the patient's name and address, the prescriber's name, address, and DEA registration number, the date, the drug name, strength, quantity, and directions for use, and the prescriber's signature [13].

Compounded modafinil is not FDA-approved and is not subject to the same quality-control testing as commercially manufactured tablets. Patients should use only pharmacies that operate under USP 795 standards for non-sterile compounding.

What Is the Cheapest Way to Get Modafinil in Arkansas?

The lowest cost pathway for most Arkansas patients without insurance coverage is generic modafinil purchased with a discount card at a high-volume pharmacy. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) listed modafinil 200 mg #30 at approximately $23 in early 2026, including dispensing fee, making it the lowest publicly available cash price for a Schedule IV prescription drug of this class in the country. The pharmacy ships to Arkansas and is licensed in the state.

For patients with an Arkansas Medicaid or CHIP enrollment, the PA route described above is the best financial pathway because approved claims result in $0, $3 copays under the Arkansas Medicaid cost-sharing schedule for Schedule IV drugs [5].

Patients with commercial insurance who have not yet met their deductible may find that a GoodRx coupon price is lower than their insurance negotiated rate. This is legal; patients may choose to pay cash for a prescription rather than use insurance on any given fill, per CMS guidance [14]. Pharmacists are not required to volunteer this comparison, so patients should ask.

The Provigil manufacturer (Jazz Pharmaceuticals, which acquired the Provigil brand from Cephalon) offers a patient assistance program for brand-name Provigil for patients who meet income eligibility requirements (generally at or below 400% of the federal poverty level). Arkansas patients can apply through the NeedyMeds database or directly through Jazz's patient support line [15].

A 2019 analysis in the Annals of Internal Medicine examined prescription drug cost-sharing for sleep disorder medications and found that patients who used pharmacy discount programs saved a mean of 58% compared with their insurance copay when the deductible had not been met [16]. That figure is consistent with what Arkansas patients report when switching from in-network insurance billing to a GoodRx coupon at the same pharmacy.

How Does Telehealth Prescribing of Modafinil Work in Arkansas?

Arkansas permits telehealth prescribing of Schedule IV controlled substances under state law, subject to a valid prescriber-patient relationship. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires that a prescriber conduct at least one in-person evaluation before prescribing a controlled substance via telemedicine, unless a specific DEA exception applies [17]. The DEA issued a temporary telemedicine rule during the COVID-19 public health emergency that allowed remote Schedule IV prescribing without a prior in-person visit; that exception has been extended through 2025 and is under active rulemaking as of early 2026 [18].

Practically: an Arkansas patient can complete a telehealth visit with a DEA-registered prescriber licensed in Arkansas, receive a diagnosis supported by the clinical interview and any uploaded sleep study documentation, and receive an electronic prescription for modafinil transmitted to an Arkansas-licensed pharmacy. HealthRX operates under these rules and requires board-certified physician review of all modafinil prescriptions.

The Arkansas State Medical Board requires that telehealth encounters meet the same standard of care as in-person visits. For modafinil, that means the prescriber must document clinical findings sufficient to support the diagnosis, review prior sleep study data if available, and assess for contraindications including hypersensitivity to modafinil or armodafinil, uncontrolled hypertension, or history of drug or alcohol dependence [2].

Patients with narcolepsy type 1 (with cataplexy) should have polysomnography and a Multiple Sleep Latency Test (MSLT) showing mean sleep latency <8 minutes with two or more sleep-onset REM periods, per the AASM 2014 diagnostic criteria for narcolepsy [19]. Telehealth prescribers can review uploaded MSLT reports; an in-state sleep study is not required if the patient has existing documentation.

Modafinil Pharmacology: Why It Works and Why It Costs What It Does

Modafinil's mechanism of action is not fully established, but the most supported hypothesis involves selective inhibition of dopamine reuptake at the dopamine transporter (DAT), increasing extracellular dopamine in the nucleus accumbens and prefrontal cortex without the broad catecholamine release seen with amphetamines [20]. This selectivity is clinically relevant: modafinil produces wakefulness without the pronounced cardiovascular stimulation, appetite suppression, or dependence liability of amphetamine-class drugs [21].

The original US Modafinil in Narcolepsy Study Group trial published in Annals of Neurology (1998, N=271) found that modafinil 200 mg/day reduced the Epworth Sleepiness Scale score by a mean of 3.0 points vs. 0.8 points for placebo (P<0.001), and that 400 mg/day reduced ESS by 3.6 points [1]. Adverse events were mild: headache (34% modafinil vs. 20% placebo), nausea (11% vs. 3%), and nervousness (7% vs. 3%).

A subsequent FDA-reviewed trial for the shift work sleep disorder indication (N=278) found that modafinil 200 mg taken one hour before night shift reduced nocturnal sleepiness on the Karolinska Sleepiness Scale by a clinically meaningful margin compared with placebo [2]. These two datasets form the clinical backbone of every insurance PA letter and Medicaid coverage decision in Arkansas.

The cost history of modafinil in the U.S. reflects standard pharmaceutical patent economics. Cephalon held U.S. patent protection until 2012. Following generic entry, the average retail price fell from over $400 per 30 tablets to under $100 within 24 months, following the same trajectory documented for other post-patent small-molecule CNS drugs. The current $80 Arkansas average reflects a stable, competitive generic market with 13 manufacturers [4].

Drug interactions worth noting for Arkansas prescribers: modafinil is a moderate inducer of CYP3A4 and CYP2C19. It may reduce plasma concentrations of hormonal contraceptives (ethinyl estradiol AUC reduced by approximately 18% in pharmacokinetic studies cited in the FDA label) [2]. Women of reproductive age taking combined oral contraceptives should use a backup method during modafinil therapy and for one month after discontinuation. Modafinil may also reduce levels of cyclosporine, which is relevant for transplant patients at UAMS or other Arkansas transplant centers [22].

Arkansas-Specific Pharmacy Access and Dispensing Notes

Arkansas has 1,147 licensed retail pharmacies as of the Arkansas State Board of Pharmacy's 2025 count, including chains (Walmart, which is headquartered in Bentonville AR; CVS; Walgreens; Kroger) and independent pharmacies. Schedule IV prescriptions for modafinil may be dispensed up to a 90-day supply in Arkansas if the prescriber writes for that quantity and the clinical indication supports it; the DEA does not limit Schedule IV supply to 30 days, though some pharmacies apply a voluntary 30-day cap [13].

Rural Arkansas patients face a specific access challenge: 41 of Arkansas's 75 counties are designated Health Professional Shortage Areas (HPSAs) for mental health and primary care [23]. For these patients, telehealth prescribing combined with mail-order pharmacy dispensing is the most practical combination. Cost Plus Drugs ships to all Arkansas zip codes with a $5 flat shipping fee and no membership requirement.

Patients in the Medicaid expansion population (Arkansas expanded Medicaid under the ACA in 2014 through the "Private Option" now called Arkansas Works) are eligible for coverage of generic modafinil with a PA approval. Approximately 1.1 million Arkansans were enrolled in Arkansas Medicaid as of late 2025, representing roughly 37% of the state population [24]. For this group, the PA pathway is worth pursuing before paying cash.